167 related articles for article (PubMed ID: 34398250)
1. Comparative cardioprotective effects of carvedilol versus atenolol in a rat model of cardiorenal syndrome type 4.
Mohamed RMSM; Elshazly SM; Nafea OE; Abd El Motteleb DM
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2117-2128. PubMed ID: 34398250
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol Diminishes Cardiac Remodeling Induced by High-Fructose/High-Fat Diet in Mice via Enhancing Cardiac β-Arrestin2 Signaling.
Ibrahim WS; Ibrahim IAAE; Mahmoud MF; Mahmoud AAA
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):354-363. PubMed ID: 32052660
[TBL] [Abstract][Full Text] [Related]
3. Mitigation of dexamethasone-induced nephrotoxicity by modulating the activity of adrenergic receptors: Implication of Wnt/β-arrestin2/β-catenin pathway.
Mohamed RMSM; Ahmad EA; Omran BHF; Sakr AT; Ibrahim IAAE; Mahmoud MF; El-Naggar ME
Life Sci; 2022 Mar; 293():120304. PubMed ID: 35016879
[TBL] [Abstract][Full Text] [Related]
4. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
5. β-arrestin-biased agonism of β-adrenergic receptor regulates Dicer-mediated microRNA maturation to promote cardioprotective signaling.
Teoh JP; Bayoumi AS; Aonuma T; Xu Y; Johnson JA; Su H; Weintraub NL; Tang Y; Kim IM
J Mol Cell Cardiol; 2018 May; 118():225-236. PubMed ID: 29627294
[TBL] [Abstract][Full Text] [Related]
6. The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome.
Chua S; Lee FY; Chiang HJ; Chen KH; Lu HI; Chen YT; Yang CC; Lin KC; Chen YL; Kao GS; Chen CH; Chang HW; Yip HK
J Pineal Res; 2016 Nov; 61(4):438-456. PubMed ID: 27465663
[TBL] [Abstract][Full Text] [Related]
7. Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway.
Deng T; Wei Z; Gael A; Deng X; Liu Y; Lai J; Hang L; Yan Q; Fu Q; Li Z
J Cardiovasc Pharmacol; 2020 Jun; 75(6):535-544. PubMed ID: 32168151
[TBL] [Abstract][Full Text] [Related]
8.
Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
[No Abstract] [Full Text] [Related]
9. Adrenergic receptors blockade alleviates dexamethasone-induced neurotoxicity in adult male Wistar rats: Distinct effects on β-arrestin2 expression and molecular markers of neural injury.
Mohamed RMSM; Ahmad Ahmad E; Amin DM; Abdo SA; Ibrahim IAAE; Mahmoud MF; Abdelaal S
Daru; 2024 Jun; 32(1):97-108. PubMed ID: 37966585
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic metabolic effects of carvedilol in high-fructose, high-fat diet-fed mice: implication of β-arrestin2 pathway.
Ahmed HMS; Mohamed SG; Ibrahim WS; Rezk AM; Mahmoud AAA; Mahmoud MF; Ibrahim IAAE
Can J Physiol Pharmacol; 2022 Jan; 100(1):68-77. PubMed ID: 34570983
[TBL] [Abstract][Full Text] [Related]
11. Chronic bilateral renal denervation reduces cardiac hypertrophic remodelling but not β-adrenergic responsiveness in hypertensive type 1 diabetic rats.
Thaung HP; Yao Y; Bussey CT; Hughes G; Jones PP; Bahn A; Sammut IA; Lamberts RR
Exp Physiol; 2015 Jun; 100(6):628-39. PubMed ID: 25881071
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.
Wang Q; Wang Y; West TM; Liu Y; Reddy GR; Barbagallo F; Xu B; Shi Q; Deng B; Wei W; Xiang YK
Cardiovasc Res; 2021 Aug; 117(10):2237-2251. PubMed ID: 32956449
[TBL] [Abstract][Full Text] [Related]
14. Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy.
Yin J; Lu Z; Wang F; Jiang Z; Lu L; Miao N; Wang N
J Cell Mol Med; 2016 Jun; 20(6):1106-17. PubMed ID: 26923216
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
16. Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat.
Yang CC; Chen YT; Wallace CG; Chen KH; Cheng BC; Sung PH; Li YC; Ko SF; Chang HW; Yip HK
Biomed Pharmacother; 2019 Jan; 109():658-670. PubMed ID: 30404073
[TBL] [Abstract][Full Text] [Related]
17. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
[TBL] [Abstract][Full Text] [Related]
18. β-blockers interfere with cell homing receptors and regulatory proteins in a model of spontaneously hypertensive rats.
Eibel B; Kristochek M; Peres TR; Dias LD; Dartora DR; Casali KR; Kalil RAK; Lehnen AM; Irigoyen MC; Markoski MM
Cardiovasc Ther; 2018 Aug; 36(4):e12434. PubMed ID: 29752864
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Inflammation after Ischemia-Reperfusion of the Kidney: Role of the Sympathetic Nervous System and the Renin-Angiotensin System.
Panico K; Abrahão MV; Trentin-Sonoda M; Muzi-Filho H; Vieyra A; Carneiro-Ramos MS
Cell Physiol Biochem; 2019; 53(4):587-605. PubMed ID: 31535830
[TBL] [Abstract][Full Text] [Related]
20. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
